Clinical Trials
6 trialsNCT04549207 2026-04-07
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT00128297 2023-03-28
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Spanish Breast Cancer Research Group
Phase 4 Completed
NCT02721433 2020-12-02
REaCT-BTA
Ottawa Hospital Research Institute
Phase 4 Completed
NCT01907880 2017-07-07
ER11-03
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02101164 2015-02-18
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Amgen
Phase 4 Withdrawn
NCT02313727 2014-12-10
Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression
Bnai Zion Medical Center
Phase 4 Unknown